| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Sep'17 |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
0 | - | 0 | - | 0 | - | 0 | - | - | - |
Operating expenses: | |||||||||
Research and development | |||||||||
1,220 | 1,448 | 2,430 | 784 | 445 | 865 | 1,717 | 1,394 | 692 | 717 |
Sales and marketing | |||||||||
50 | 52 | 33 | 46 | 57 | 126 | 109 | 56 | 12 | 30 |
Depreciation and amortization | |||||||||
70 | 70 | 73 | 43 | 29 | 30 | 30 | 29 | 30 | 32 |
General and administrative | |||||||||
1,932 | 1,709 | 1,763 | 2,101 | 1,854 | 1,029 | 794 | 834 | 449 | 720 |
Total operating expenses | |||||||||
3,274 | 3,280 | 4,300 | 2,975 | 2,386 | 2,052 | 2,651 | 2,314 | 1,184 | 1,500 |
Loss from operations | |||||||||
-3,274 | -3,280 | -4,300 | -2,975 | -2,386 | -2,052 | -2,651 | -2,314 | -1,184 | -1,500 |
Other (expense) income: | |||||||||
Interest expense | |||||||||
0 | 0 | 0 | 0 | 822 | 368 | 327 | 252 | 166 | 102 |
Interest income | |||||||||
4 | - | 5 | 1 | 1 | - | 1 | 1 | 0 | - |
Other income | |||||||||
- | - | - | - | - | - | - | - | - | 2 |
Total other income (expense) | |||||||||
4 | 5 | 5 | 1 | -821 | -367 | -326 | -250 | -166 | -100 |
Loss before income taxes | |||||||||
- | - | - | -2,973 | - | - | - | -2,565 | -1,351 | -1,601 |
Net loss | |||||||||
-3,270 | -3,275 | -4,294 | -2,973 | -3,208 | -2,419 | -2,978 | -2,565 | -1,351 | -1,601 |
Dividend to Series A and B preferred stockholders | |||||||||
0 | 0 | 0 | 0 | 160 | 320 | 320 | 320 | 320 | 320 |
Net loss attributable to common stockholders | |||||||||
-3,270 | -3,275 | -4,294 | -2,973 | -3,368 | -2,739 | -3,298 | -2,885 | -1,671 | -1,921 |
Net loss per common share, basic and diluted (in dollars per share) | |||||||||
-0.19 | -0.10 | -0.27 | -0.20 | -0.43 | -1.42 | -1.74 | -1.56 | -0.92 | -1.12 |
Weighted average number of common shares outstanding, basic and diluted (in shares) | |||||||||
16,781 | 16,827 | 15,994 | 14,801 | 7,745 | 1,947 | 1,898 | 1,845 | 1,820 | 1,720 |